- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Contact Webmaster
- Website policies
- Disability services
- UF Health Home
Healing UF Health at Gainesville
- UF Health Shands Hospital
- UF Health Shands Cancer Hospital
- Shands Emergency & Trauma
- UF Health Shands Children's Hospital
- UF Health Shands Rehab Hospital
- UF Health Shands Psychiatric Hospital
- Learning UF&Shands Gainesville
Discovery UF Health at Gainesville
- Research Studies
- Genetics Institute
- Institute on Aging
- McKnight Brain Institute
- UF Diabetes Institute
- Community UF Health at Gainesville
- visit University of Florida
- About Us
- Clinical Trials
Read about Sam’s journey — including why his parents eventually decided to enroll him in a phase 3 clinical trial — in our new patient magazine, UFHCC Cares.
Head and neck cancer survivor shares story of recovery
A Hodgkin lymphoma patient shares his advice for supporting a loved one during cancer.
The President of UF Health’s annual “year-in-review” column features the UF Health Cancer Center.Read More
June 26, 2017
A genetic variation identified by researchers at University of Florida Health may help clinicians target a deadly form of leukemia using a promising drug therapy.
June 12, 2017
For media inquiries, contact Matt Splett at 352-273-6873 or email firstname.lastname@example.org or Sharon Witherell at the Institute of International Education at email@example.com
May 26, 2017
A new phase II clinical trial currently enrolling patients with glioblastoma is the first clinical research collaboration of University of Florida Health’s joint oncology program with Orlando...
May 23, 2017
In a study of three radiation therapies for early-stage breast cancer, one treatment option stands out as offering the most value based on factors including health outcomes, cost-effectiveness and...
We spoke with Christina Cline, R.N., recently to her to learn about what the role entails — including some of its most rewarding and and challenging aspects.
In this role, Dr. Shenkman will be responsible for overseeing the center-wide effort to reduce cancer-related disparities and burden through research in clinical and community settings that addresses prevention, treatment and survivorship.
A study suggests that certain types of immune cells found in cancer — myeloid-derived suppressor cells, or MDSCs — are also present in certain patients diagnosed with severe sepsis and septic shock.